phenylketonuria

27
Hyperphe nylalani n aemia Sarah M. Alfaqaih ,MD MBBS , AB Clinical fellowship KHMC ( Royal medical services ) of inherited metabolic disorder

Transcript of phenylketonuria

Page 1: phenylketonuria

Hyperphenylalanin

aemia

Sarah M. Alfaqaih ,MDMBBS , ABClinical fellowship KHMC ( Royal medical services ) of inherited metabolic disorder

Page 2: phenylketonuria

Content: Introduction Metabolic derangement Clinical presentation Diagnosis workup Treatment Prognosis

Page 3: phenylketonuria

Defect in either PAH or the production or recycling of BH4 may cause hyper-PAH .

Autosomal recessive defect The PAH gene located on long arm

chromosome 12 No single prevalent mutation

Page 4: phenylketonuria

The prevalence varies between different population :

1 in million in Finland 1 in 2400 in Turkey

Page 5: phenylketonuria

Introduction Metabolic derangement Clinical presentation Diagnosis workup Treatment Prognosis

Page 6: phenylketonuria
Page 7: phenylketonuria

Pathogenesis of brain damage of PKU is not fully understood

Tyrosine becomes semi-essential amino acid , with reduced blood levels leading to impaired synthesis of melanine , dopamine and norephinephrine

Increased blood level of PHA results in an imbalance of other large neutral amino acid within the brain ( decrease TYR , serotonin )

Page 8: phenylketonuria

Introduction Metabolic derangement Clinical presentation Diagnosis workup Treatment Prognosis

Page 9: phenylketonuria

Mousy odour ( phenylacetic acid ) Eczema 20-40% Sever mental retardation IQ<= 50 Reduced hair , skin and iris

pigmentation Reduced growth and microcephaly

and neurological impairments: 25% epilepsy , 30% tremor , 5% spasticiy of limbs , 80% EEG abnormalities

Page 10: phenylketonuria

The face of this patient with PKU illustrates the rather subtle eczematoid rash. The brown eyes remind us that all patients with this disease do not have blue eyes. In addition, he had epicanthal folds and a left internal strabismus

Fig:1(2)

Page 11: phenylketonuria

Severely retarded, institutionalized brothers with untreated PKU. They were quite fair of hair

and skin.Fig:2(2)

Page 12: phenylketonuria

Almost all untreated patients show behavioral problems , which include hyperactivity , purposeless movements , aggressiveness , anxiety and social withdrawal .

The clinical phenotype correlate with PHE blood level .

Page 13: phenylketonuria

Introduction Metabolic derangement Clinical presentation Diagnosis workup Treatment Prognosis

Page 14: phenylketonuria

PKU is detected by neonatal secrening ( Guthrie , enzymatic techniques , tandum mass spectrometry ).

PHE level that is taken as a positive result requiring further investigation (120-240µmol\l , also PHE\TYR ratio >3 used in some labs ).

Page 15: phenylketonuria

A positive ferric chloride test in a patient with untreated

PKU.Fig:3 (2)

Page 16: phenylketonuria
Page 17: phenylketonuria

Introduction Metabolic derangement Clinical presentation Diagnosis workup Treatment Prognosis

Page 18: phenylketonuria

Principle of treatment Dietary treatment

PHE free amino acid formula .Breast milk has a relatively low amount of PHE.Meat , fish , milk , yogurt ,cream , egg , rice and cheese contains a higher concentration of PHE.

Page 19: phenylketonuria

(2)

Page 20: phenylketonuria

(2)

9

Page 21: phenylketonuria

Treatment with BH4BH4 can reduce level of PHE in some patient with PKU BH4 responsiveness is determined by reduction of >= 30% in blood PHE level after a single dose of 10mg\kg body weight

Page 22: phenylketonuria

Monitoring of treatment(1)

Page 23: phenylketonuria

Alternative treatment Gene therapy : the development of

a safe and more successful gene transfere vector is still required before clinical trial in humans

Liver transplantation : the risk of transplantation surgery and post-transplantation immune suppressive medication are too high for it to be a realistic alternative .

Phenylalanine ammonia lyase

Page 24: phenylketonuria

Introduction Metabolic derangement Clinical presentation Diagnosis workup Treatment Prognosis

Page 25: phenylketonuria

The outcome is expected to be very good if the diet is closely followed, starting shortly after the child's birth. If treatment is delayed or the condition remains untreated, brain damage will occur. School functioning may be mildly impaired.

If proteins containing phenylalanine are not avoided, PKU can lead to intellectual disability by the end of the first year of life.

Page 26: phenylketonuria

Reference

1)Jean-Marie Saudubray ,Georges van den Berghe , John H. Walter (Editors) Inborn Metabolic Disease Diagnosis and Treatment, Fifth Edition2)William L. Nyhan , Bruce A. Barsho , Pinar T. Ozand, Atlas of Metabolic Diseases Second edition

Page 27: phenylketonuria

THANKS FOR ATTENSION